EVs containing BACE1 siRNAs have also been used in C57BL/6 mice resulting in an over 60% reduction in BACE1 mRNA and a 55% decrease in β-amyloid 1-42 levels, a key component of plaques in AD pathology [155]. The gene discussed is BACE1; the disease is Alzheimer disease.